MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity.
Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop.
Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120.
Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.
Class II (I-Ad) restricted T-cell recognition of the V3 loop region of HIV-1 gp120.
Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2-V3 interaction and modulates neutralization sensitivity.
Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody.
Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study.
Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.
A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy.
Sulfated polyester interactions with the CD4 molecule and with the third variable loop domain (v3) of gp120 are chemically distinct.
Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop.
Rapid in vivo induction of HIV-specific CD8+ cytotoxic T lymphocytes by a 15-amino acid unmodified free peptide from the immunodominant V3-loop of GP120.
The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.
Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1.
Cryptic determinant of α4β7 binding in the V2 loop of HIV-1 gp120.
NMR observation of HIV-1 gp120 conformational flexibility resulting from V3 truncation.
Discovery of novel anti-HIV-1 agents based on a broadly neutralizing antibody against the envelope gp120 V3 loop: a computational study.
Negatively charged glyconanoparticles modulate and stabilize the secondary structures of a gp120 V3 loop peptide: toward fully synthetic HIV vaccine candidates.
Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies.
Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles.
Structural dynamics of V3 loop in a trimeric ambiance, a molecular dynamics study on gp120-CD4 trimeric mimic.
European consensus.
Short Communication: HIV-1 Variants That Use Mouse CCR5 Reveal Critical Interactions of gp120's V3 Crown with CCR5 Extracellular Loop 1.
The role of the V3 loop of gp120 in HIV infection.
The role of the V3 loop of gp120 in HIV infection. - PDF Download Free
1MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity.
Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop.
Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120.
Effect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.
Class II (I-Ad) restricted T-cell recognition of the V3 loop region of HIV-1 gp120.
Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2-V3 interaction and modulates neutralization sensitivity.
Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody.
Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study.
Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.
A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms